Sanigen Co. Ltd (KOSDAQ:188260)
South Korea · Delayed Price · Currency is KRW 1,999.00
+461.00 (29.97%)
At close: Mar 12, 2026
Sanigen Co. Revenue
In the year 2025, Sanigen Co. had annual revenue of 15.35B KRW, down -0.48%. Sanigen Co. had revenue of -4.94B in the quarter ending December 31, 2025.
Revenue
15.35B
Revenue Growth
-0.48%
P/S Ratio
0.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.35B | -73.62M | -0.48% |
| Dec 31, 2024 | 15.43B | -4.76B | -23.57% |
| Dec 31, 2023 | 20.19B | -6.57B | -24.56% |
| Dec 31, 2022 | 26.76B | 1.54B | 6.09% |
| Dec 31, 2021 | 25.22B | 1.73B | 7.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 117.11B |
| Corentec | 106.14B |
| Alpha AI | 25.98B |
| Bio Protech | 20.58B |
| Finemedix | 10.48B |
| Genolution | 9.15B |
| Celemics | 6.13B |
| TASCOM | 5.53B |